Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

Forecast-beating sales today boosted Burberry turnaround hopes as the luxury goods group moved closer to a FTSE 100 return.

Because AVUS is an ETF, it's best compared with Vanguard's Total Stock Market Index ETF VTI. In that same period, the cumulative gain for VTI was 91.9%. Although that outperformance by AVUS is far ...

Five magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and well beyond).

Corundum Group Inc. increased its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 46.6% during the fourth ...

CHINESE firms are attracting investors with increased dividends and buybacks, spurred by a policy push for corporate ...

The U.S. stock market closed higher Thursday, bringing the year-to-date gain of the SPDR S&P 500 ETF Trust SPY to 4%. The S&P 500 climbed 0.5% on Thursday to a record high, lifted by a broad rally ...

Ameritas Advisory Services LLC lessened its position in shares of TotalEnergies SE (NYSE:TTE – Free Report) by 21.7% in the ...

A big question for UK investors is how much to pump into shares with the aim of achieving meaningful passive income down the ...

The dividend yield on Chinese stocks has risen to around 3%, the highest since 2016, rewarding investors who have bravely ...

Investing.com -- Shares of Gjensidige Forsikring surged 8.6% following the release of its fourth-quarter financial results, which exceeded market expectations. The Norwegian insurer reported a profit ...

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 24th: ICL ...